3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Head & Neck
2
Gynecologic
2
Tumor-Agnostic
1
Thoracic
1
Myeloid
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Blood Specimen Collection
15
Imatinib Mesylate
10
Flow Cytometry
10
nilotinib
8
Surveys and Questionnaires
8
Polymerase Chain Reaction
8
ponatinib
6
Cytogenetic Analysis
6
ruxolitinib
5
bosutinib
5
Psychiatric Rehabilitation
5
Dasatinib
5
Therapeutics
4
Interviews as Topic
4
Biopsy
4
asciminib
3
Observation
3
Microarray Analysis
3
In Situ Hybridization, Fluorescence
3
Immunoenzyme Techniques
3
Amplified Fragment Length Polymorphism Analysis
3
olverembatinib
2
fludarabine
2
Watchful Waiting
2
Tyrosine Kinase Inhibitors
2
Molecular Diagnostic Techniques
2
Influenza Vaccines
2
Immunologic Techniques
2
Immunohistochemistry
2
Hydroxyurea
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
DNA
×
Myeloid
×
Clear all
NCT05605379
2024-08-14
CML Piramid
University Hospital, Bordeaux
Recruiting
88 enrolled